BNB news today centers on a Nasdaq suspension hitting BNB Plus Corp, trading under ticker BNBX. Starting at market open on July 14, the company's common stock stops trading on the trading platform and moves to the OTCQB Venture Market under the same ticker.
Source: Official Statement
So, why is a Binance coin reserve asset company facing the delisting from one of the major exchanges?
The suspension comes after BNBX shares failed to hold Nasdaq's minimum $1.00 closing bid price under Listing Rule 5550(a)(2), a rule that trips up small-cap companies across many sectors.
The delisting determination followed a standard 30-day deficiency notice period along with extensions, giving BNB Plus time to recover its share price. That recovery never happened. Shares recently traded between $0.15 and $0.38, down over 92% across the past year.
Rule violated: Listing Rule 5550(a)(2), minimum $1.00 closing bid price
Suspension date: market open, July 14
New venue: OTCQB Venture Market
Ticker: BNBX, unchanged from Nasdaq listing
Nasdaq has also tightened enforcement on sub-$1 stocks recently, capping non-compliance windows and limiting repeated reverse splits. That stricter stance played a direct role in how fast this suspension arrived.
BNB Plus started out as Applied DNA Sciences, a biotech company focused on nucleic acid production, DNA tagging, and therapeutics.
In 2025, the company rebranded and pivoted toward a digital asset treasury strategy built around $BNB as its primary reserve asset. That shift used Binance ecosystem tools for yield generation, alongside some remaining legacy biotech contracts.
A private placement helped fund the $BNB treasury portion of the business. Investor skepticism toward this hybrid biotech-crypto model, combined with declining legacy revenue and dilution pressure, kept the stock price depressed even as the strategy took shape.
The stock's slide below $1 stretched on for an extended period before Nasdaq issued its determination. Market cap for BNB-Plus has recently sat under $10 million (currently at $1.17 million), a sharp contrast to $BNB price itself, the token trading around $570 with a market cap near $76.88B.
BNBX stock: At $0.16, down 56%
Last closed at $0.37
Today’s Range: $.18–$0.15
Share Volume: 5.34 million
Market Cap: 1,173,148
Source: Google Finance
This gap matters. The firm holds $BNB coin as a reserve asset, yet its own stock performance has moved almost entirely opposite to the token's stability near the $570 mark.
Moving to OTCQB brings some reporting requirements and visibility, but liquidity drops sharply compared to Nasdaq. Wider spreads, less institutional interest, and generally lower valuations tend to follow small-cap companies once they leave a major exchange.
$BNBX plans to request a review from the Nasdaq Listing and Hearing Review Council, though that request does not pause the suspension itself.
Management has stated the OTCQB transition will not affect business operations, meaning the $BNB treasury strategy, yield activities, and remaining biotech contracts continue as before.
For current shareholders, this raises real risk: penny-stock status tends to amplify volatility, though $BNBcoin exposure could still benefit if the broader $BNB ecosystem or a crypto market upswing lifts $BNB holdings in value.
Bid-price delistings like this happen often among micro-cap stocks, spanning biotech, EV firms, and now crypto-treasury companies as Nasdaq enforces tighter rules. Recovery is possible if $BNBX sustains a $1 or higher closing bid for 10 consecutive trading days, often through a reverse split, positive treasury results, or renewed biotech order flow. History shows most companies that shift to OTC markets stay there for years unless fundamentals improve substantially.
BNB Plus now carries the weight of proving its treasury model can work under public scrutiny, separate from how BNB itself performs in the broader market.
Next major updates could be quarterly results, BNB holdings disclosures, and any Nasdaq relisting progress, since none of those outcomes are guaranteed from here.
Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Crypto markets carry significant risk. Always do your own research before making any investment decisions.
